CD74: a potential novel target for triple-negative breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s13277-012-0489-x.pdf
Reference14 articles.
1. Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol. 2007;608:1–22.
2. Kasami M, Uematsu T, Honda M, et al. Comparison of estrogen receptor, progesterone receptor and Her-2 status in breast cancer pre- and post-neoadjuvant chemotherapy. Breast. 2008;17:523–7.
3. Curado MP. Breast cancer in the world: incidence and mortality. Salud Publica Mex. 2011;53(5):372–84.
4. Liu C, Chen B, Zhu J, Zhang R, Yao F, Jin F, et al. Clinical implications for nestin protein expression in breast cancer. Cancer Sci. 2010;101(3):815–9.
5. Krop IE, Lorusso P, Miller KD, Modi S, Yardley D, Rodriguez G, et al. A phase II study of trastuzumab emtansine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who were previously treated with trastuzumab, lapatinib, an anthracycline, a taxane, and capecitabine. J Clin Oncol. 2012. doi: 10.1200/JCO.2011.40.5902
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunohistochemical study of CD74 biomarker in normal and malignant breast tissues;Polski Merkuriusz Lekarski;2024
2. The invariant chain CD74 protein is a cell surface binding partner of TIMP‐1 in breast cancer cells;Molecular Oncology;2023-04-28
3. The biomarkers related to immune infiltration to predict distant metastasis in breast cancer patients;Frontiers in Genetics;2023-02-22
4. The biomarkers related to immune infiltration to predict distant metastasis in patients with breast cancer;2022-12-28
5. CD74 and HLA-DRA in Cervical Carcinogenesis: Potential Targets for Antitumour Therapy;Medicina;2022-01-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3